# Adrian F. Hernandez

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/adrian-f-hernandez/

## Facts

| Field | Value |
| --- | --- |
| Citations | 87,166 |
| Field | Heart Failure Treatment and Management |
| h-index | 134 |
| i10-index | 790 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5012849300 |
| ORCID iD | 0000-0003-3387-9616 |
| Works | 1,554 |

## Researcher papers

Showing 12 of 34.

- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/)
- [Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effects-of-once-weekly-exenatide-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [Diuretic Strategies in Patients with Acute Decompensated Heart Failure](https://scholariq.org/papers/diuretic-strategies-in-patients-with-acute-decompensated-heart-failure/)
- [Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/vericiguat-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Medical Therapy for Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/medical-therapy-for-heart-failure-with-reduced-ejection-fraction/)
- [Effect of Nesiritide in Patients with Acute Decompensated Heart Failure](https://scholariq.org/papers/effect-of-nesiritide-in-patients-with-acute-decompensated-heart-failure/)
- [Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/effect-of-phosphodiesterase-5-inhibition-on-exercise-capacity-and-clinical/)
- [Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction](https://scholariq.org/papers/heart-failure-with-preserved-borderline-and-reduced-ejection-fraction/)
- [Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome](https://scholariq.org/papers/ultrafiltration-in-decompensated-heart-failure-with-cardiorenal-syndrome/)
- [SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.